• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Int J Cardiol - Association among myocardial injury and mortality in Influenza: A prospective cohort study

tetano

Editor, Senior Moderator
Int J Cardiol


. 2022 Aug 6;S0167-5273(22)01182-2.
doi: 10.1016/j.ijcard.2022.08.016. Online ahead of print.
Association among myocardial injury and mortality in Influenza: A prospective cohort study


Luigi Biasco[SUP] 1 [/SUP], Amabile Valotta[SUP] 2 [/SUP], Catherine Klersy[SUP] 3 [/SUP], Marco Valgimigli[SUP] 4 [/SUP], Luca Gabutti[SUP] 5 [/SUP], Roberto Della Bruna[SUP] 6 [/SUP], Alberto Pagnamenta[SUP] 7 [/SUP], Lorenzo Ruinelli[SUP] 8 [/SUP], Gaetano Senatore[SUP] 9 [/SUP], Giovanni B Pedrazzini[SUP] 10 [/SUP]



Affiliations

Abstract

Background: Myocardial injury (MINJ) is a well-recognized prognostic marker in different acute cardio-respiratory illnesses, nonetheless, its relevance in Influenza remains poorly defined. Our aim was to assess incidence, correlates, short and mid-term prognostic role of MINJ in Influenza.
Methods: Hospitalized patients (pts) with laboratory confirmed Influenza A or B underwent highly sensitive cardiac T Troponin (hs-cTnT) measurement at admission in four regional Swiss hospitals during the 2018-2019 epidemic. MINJ was defined as hs-cTnT >14 ng/L. Clinical, laboratory and outcome data were prospectively collected. The primary endpoint was mortality at 28 days while the composite of mortality, admission to intensive care unit (ICU) or need for mechanical ventilation at 28-days and mortality at 30-months were set as secondary endpoints.
Results: The presence of MINJ was assessed within 48 h from admission in 145 consecutive hospitalized pts., being evident in 94 (65.5%) pts. and associated with older age, higher C-reactive protein levels, renal impairment or chronic obstructive pulmonary disease. At a 28-days follow-up, 7 deaths (4.8%) occurred, all in patients with MINJ at admission (log-rank p = 0.048). MINJ was strongly associated with occurrence of death, ICU admission or mechanical ventilation (OR 5.74, 95% CI 1.28-53.29; p = 0.015). After a median follow-up of 32.7 months (IQR 32.2-33.4), 15 (10.3%) deaths occurred, all among pts. with MINJ at index hospitalization leading to a higher mortality at follow-up among patients with MINJ (log-rank p = 0.003).
Conclusions: MINJ is common in patients hospitalized for Influenza and is able to stratify the risk of short-term adverse events and mid-term mortality.

Keywords: Biomarker; Influenza; Mortality; Myocardial injury; Myocarditis; Troponin.
 
Back
Top Bottom